The story of Viagra presents a challenging picture for shareholders. While the initial release generated substantial gains, the end of its exclusive rights opened the floodgates to cheaper versions, dramatically https://isocialfans.com/story7226318/sildenafil-and-the-pharmaceutical-industry-a-volatile-investment